-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EDlYWpDCmbPnytv6O9doy0lSWLObBpI79S8fR1MY2xkqvvWMfgJ/3t7yeBeMggig 7OTa8ZVVsC+vfPMHGIhy5A== 0000892569-99-000751.txt : 19990329 0000892569-99-000751.hdr.sgml : 19990329 ACCESSION NUMBER: 0000892569-99-000751 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990326 GROUP MEMBERS: COOPER & LEVASSEUR, LLC GROUP MEMBERS: COOPER CAPITAL, LLC GROUP MEMBERS: COOPER PETER C GROUP MEMBERS: GILBERT E. LEVASSEUR, JR. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: APRIA HEALTHCARE GROUP INC CENTRAL INDEX KEY: 0000882289 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 330488566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-42598 FILM NUMBER: 99574963 BUSINESS ADDRESS: STREET 1: 3560 HYLAND AVE STREET 2: C/O APRIA HEALTHCARE GROUP INC CITY: COSTA MESA STATE: CA ZIP: 92626 BUSINESS PHONE: 7144272000 MAIL ADDRESS: STREET 1: 3560 HYLAND AVENUE STREET 2: C/O APRIA HEALTHCARE GROUP INC CITY: COSTA MESA STATE: CA ZIP: 92626 FORMER COMPANY: FORMER CONFORMED NAME: ABBEY HEALTHCARE GROUP INC/DE DATE OF NAME CHANGE: 19930328 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: COOPER PETER C CENTRAL INDEX KEY: 0001082790 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 2010 MAIN ST STREET 2: SUITE 1220 CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492511400 MAIL ADDRESS: STREET 1: 2010 MAIN ST STREET 2: SUITE 1220 CITY: IRVINE STATE: CA ZIP: 92614 SC 13D 1 SCHEDULE 13D 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13-2(a) Apria Healthcare Group, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, Par Value $0.001 - -------------------------------------------------------------------------------- (Title of Class of Securities) 037933108 - -------------------------------------------------------------------------------- (CUSIP Number) Peter C. Cooper Cooper & LeVasseur, LLC 2010 Main Street, Suite 1220 Irvine, California 92614 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 17, 1999 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.113d-1(g), check the following box. [ ] 2 CUSIP No. 037933108 Schedule 13D Page 2 of 11 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Peter C. Cooper - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Source of Funds (See Instructions): See Item 3 below - -------------------------------------------------------------------------------- 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization: New Zealand - -------------------------------------------------------------------------------- Number of 7. Sole Voting Power: 948,950 Shares ---------------------------------------------------------------- Beneficially 8. Shared Voting Power: 1,089,000 Owned ---------------------------------------------------------------- by Each 9. Sole Dispositive Power: 948,950 Reporting ---------------------------------------------------------------- Person With 10. Shared Dispositive Power: 1,089,000 - -------------------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person: 2,836,900 - -------------------------------------------------------------------------------- 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] - -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11): 5.5% - -------------------------------------------------------------------------------- 14. Type of Reporting Person (See Instructions) IN 3 CUSIP No. 037933108 Schedule 13D Page 3 of 11 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Gilbert E. LeVasseur, Jr. - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Source of Funds (See Instructions): See Item 3 below - -------------------------------------------------------------------------------- 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization: USA - -------------------------------------------------------------------------------- Number of 7. Sole Voting Power: 798,950 Shares ---------------------------------------------------------------- Beneficially 8. Shared Voting Power: 1,089,000 Owned ---------------------------------------------------------------- by Each 9. Sole Dispositive Power: 798,950 Reporting ---------------------------------------------------------------- Person With 10. Shared Dispositive Power: 1,089,000 - -------------------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person: 2,836,900 - -------------------------------------------------------------------------------- 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] - -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11): 5.5% - -------------------------------------------------------------------------------- 14. Type of Reporting Person (See Instructions) IN 4 CUSIP No. 037933108 Schedule 13D Page 4 of 11 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Cooper & LeVasseur, LLC; EIN: 33-0815143 - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Source of Funds (See Instructions): See Item 3 below - -------------------------------------------------------------------------------- 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization: Delaware - -------------------------------------------------------------------------------- Number of 7. Sole Voting Power: 1,089,000 Shares --------------------------------------------------------------- Beneficially 8. Shared Voting Power: 0 Owned --------------------------------------------------------------- by Each 9. Sole Dispositive Power: 1,089,000 Reporting --------------------------------------------------------------- Person With 10. Shared Dispositive Power: 0 - -------------------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person: 2,836,900 - -------------------------------------------------------------------------------- 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] - -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11): 5.5% - -------------------------------------------------------------------------------- 14. Type of Reporting Person (See Instructions) OO 5 CUSIP No. 037933108 Schedule 13D Page 5 of 11 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Cooper Capital, LLC; EIN: 33-0676298 - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Source of Funds (See Instructions): See Item 3 below - -------------------------------------------------------------------------------- 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization: Delaware - -------------------------------------------------------------------------------- Number of 7. Sole Voting Power: 948,950 Shares --------------------------------------------------------------- Beneficially 8. Shared Voting Power: 1,089,000 Owned --------------------------------------------------------------- by Each 9. Sole Dispositive Power: 948,950 Reporting --------------------------------------------------------------- Person With 10. Shared Dispositive Power: 1,089,000 - -------------------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person: 2,836,900 - -------------------------------------------------------------------------------- 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] - -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11): 5.5% - -------------------------------------------------------------------------------- 14. Type of Reporting Person (See Instructions) OO 6 Item 1. Security and Issuer This Schedule 13D relates to shares of common stock, par value $0.001 (the "Common Stock"), of Apria Healthcare Group, Inc., a Delaware corporation (the "Issuer"). The principal executive office and mailing address of the Issuer is 3560 Hyland Avenue, Costa Mesa, California 92626. Item 2. Identity and Background This Schedule 13D is being filed by Peter C. Cooper ("Cooper"), Gilbert E. LeVasseur, Jr. ("LeVasseur"), Cooper & LeVasseur, LLC, a Delaware limited liability company ("Cooper & LeVasseur"), and Cooper Capital, LLC, a Delaware limited liability company ("Cooper Capital") (collectively, the "Reporting Persons"). The principal business office address of each of the Reporting Persons is 2010 Main Street, Suite 1220, Irvine, California 92614. Each of Peter C. Cooper and Gilbert E. LeVasseur, Jr. are private investors who also serve as controlling persons of certain other investment entities. Peter C. Cooper is the sole manager of Cooper Capital, a limited liability company which serves as the general partner or managing member of certain private investment funds. Cooper Capital and Mr. LeVasseur are the managing members of Cooper & LeVasseur. Cooper & LeVasseur is the sole general partner of C&L Capital Partners, L.P., a Delaware limited partnership ("Fund I"), and C&L Capital Partners II, L.P., a Delaware limited partnership ("Fund II"). Fund I and Fund II are private investment funds, investing in securities of both private and public companies. Cooper Capital also serves as general partner of Clifton Investments, L.P., a Delaware limited partnership ("Clifton"), which is a private investment fund. Mr. LeVasseur also serves as trustee of the Gilbert E. LeVasseur, Jr. Revocable Trust ("LeVasseur Trust"). To the best knowledge of the Reporting Persons, none of the entities or persons identified in this Item 2 has, during the past five years, been convicted of any criminal proceeding (excluding traffic violations or similar misdemeanors), nor been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Item 3. Source and Amount of Funds or Other Consideration Fund I, Fund II, Clifton and LeVasseur Trust used funds in the amount of $3,881,912, $1,981,564, $5,231,371 and $6,070,475 to purchase the Common Stock, respectively. All funds used to purchase the shares of Common Stock of the Issuer on behalf of Fund I, Fund II and Clifton came directly from the assets of such entities. The source of funds for the purchases by the LeVasseur Trust was the investment assets of the LeVasseur Trust. 6 7 Item 4. Purpose of Transaction The purpose of the acquisition of the Common Stock is for investment, and the acquisitions of the Common Stock were made in the ordinary course of business and were not made for the purpose of acquiring control of the Issuer. Although no Reporting Person has any specific plan or proposal to acquire or dispose of the Common Stock, consistent with its investment purpose, each Reporting Person at any time and from time to time may acquire additional Common Stock or dispose of any or all of its Common Stock depending upon an ongoing evaluation of the investment in the Common Stock, prevailing market conditions, other investment opportunities, liquidity requirements of the Reporting Persons and/or other investment considerations. Also, consistent with the investment purpose, the Reporting Persons may engage in communications with one or more shareholders of the Issuer, one or more officers of the Issuer and/or one or more members of the board of directors of the Issuer and/or one or more representatives of the Issuer regarding the Issuer, including, but not limited to, its operations. The Reporting Persons may discuss ideas that, if effected, may result in any of the following: the acquisition by persons of additional Common Stock of the Issuer, an extraordinary corporate transaction involving the Issuer, and/or changes in the board of directors or management of the Issuer. Except to the extent the foregoing may be deemed a plan or proposal, none of the Reporting Persons has any plans or proposals which relate to, or could result in, any of the matters referred to in paragraph (a) through (j), inclusive, of the instructions to Item 4 of Schedule 13D. The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto. Item 5. Interest in Securities of the Issuer (a) and (b). According to the Issuer's most recent From 10-Q, there were 51,779,059 shares of Common Stock issued and outstanding as of October 30, 1998. Based on such information and after taking into account the transactions described in Item 5(c) below, (i) each of Cooper, LeVasseur, Cooper & LeVasseur and Cooper Capital beneficially owns 2,836,900 shares of Common Stock, which represents 5.5% of the outstanding shares of the Common Stock of the Issuer. Fund I beneficially owns 783,300 shares of the Common Stock (approximately 1.5% of the total number of outstanding shares of Common Stock). Fund II beneficially owns 305,700 shares of the Common Stock (approximately 0.6% of the total number of outstanding shares of Common Stock). Clifton beneficially owns 948,950 shares of the Common Stock (approximately 1.8% of the total number of outstanding shares of Common Stock). The LeVasseur Trust owns 798,950 shares of the Common Stock (approximately 1.5% of the total number of outstanding shares of Common Stock). 7 8 Mr. Cooper, through Cooper Capital, possesses (i) sole power to vote and direct the disposition of all shares of Common Stock owned by Clifton, and (ii) shared power to vote and direct the disposition, through Cooper & LeVasseur, of all shares of Common Stock owned by each of Fund I and Fund II. Mr. LeVasseur possesses (i) sole power to vote and direct the disposition of all shares of Common Stock owned by the LeVasseur Trust, and (ii) shared power to vote and direct the disposition, through Cooper & LeVasseur, of all shares of Common Stock owned by each of Fund I and Fund II. As a result, Cooper & LeVasseur, and its managing members, Gilbert E. LeVasseur, Jr. and Cooper Capital, and its manager, Peter C. Cooper, may be deemed to beneficially own the shares of Common Stock directly owned by Fund I and Fund II. Further, Cooper Capital, and its manager, Peter C. Cooper, may be deemed to beneficially own the shares of Common Stock directly owned by Clifton. Finally, Mr. LeVasseur may be deemed to beneficially own the shares of Common Stock directly owned by the LeVasseur Trust. (c) During the last 60 days, the Reporting Persons, or other parties identified in Item 2 purchased the following shares of Common Stock in the open market:
Entity Date of Transaction Number of Shares Price Per Share - --------------- ------------------- ---------------- --------------- Clifton March 26, 1999 41,250 $7.45 LeVasseur Trust March 26, 1999 41,250 7.45 Clifton March 25, 1999 17,350 7.37 LeVasseur Trust March 25, 1999 17,350 7.37 Clifton March 24, 1999 20,000 7.34 LeVasseur Trust March 24, 1999 20,000 7.34 Clifton March 23, 1999 30,700 7.68 LeVasseur Trust March 23, 1999 30,700 7.68 Clifton March 18, 1999 10,000 7.88 LeVasseur Trust March 18, 1999 10,000 7.88 Clifton March 17, 1999 12,500 7.95 LeVasseur Trust March 17, 1999 12,500 7.95
(d) and (e) Not Applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer None of the Reporting Persons or, to the best knowledge of the Reporting Persons, the other persons named in Item 2, is a party to any contract, arrangement, 8 9 understanding or relationship with respect to any securities of the Issuer, including but not limited to, the transfer or voting of any securities of the Issuer, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies, except as previously disclosed. Item 7. Material to be Filed as Exhibits Exhibit A: Joint Filing Agreement 9 10 SIGNATURES After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: March 26, 1999 /s/ Peter C. Cooper ---------------------------------- Peter C. Cooper /s/ Gilbert E. LeVasseur, Jr. ---------------------------------- Gilbert E. LeVasseur, Jr. COOPER & LeVASSEUR, LLC, By: Cooper Capital, LLC, Member By: /s/ Peter C. Cooper ------------------------------- Peter C. Cooper, Manager By: /s/ Gilbert E. LeVasseur, Jr. ------------------------------- Gilbert E. LeVasseur, Jr., Manager COOPER CAPITAL, LLC By: /s/ Peter C. Cooper ------------------------------- Peter C. Cooper, Manager 10 11 EXHIBIT A JOINT FILING UNDERTAKING The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party. Dated: March 26, 1999 /s/ Peter C. Cooper ---------------------------------- Peter C. Cooper /s/ Gilbert E. LeVasseur, Jr. ---------------------------------- Gilbert E. LeVasseur, Jr. COOPER & LeVASSEUR, LLC, By: Cooper Capital, LLC, Member By: /s/ Peter C. Cooper ------------------------------- Peter C. Cooper, Manager By: /s/ Gilbert E. LeVasseur, Jr. ------------------------------- Gilbert E. LeVasseur, Jr., Manager COOPER CAPITAL, LLC By: /s/ Peter C. Cooper ------------------------------- Peter C. Cooper, Manager 11
-----END PRIVACY-ENHANCED MESSAGE-----